DaVita Inc. logo

DaVita Inc. (DVA)

Market Open
25 Jul, 19:44
NYSE NYSE
$
144. 79
+0.02
+0.01%
$
10.53B Market Cap
16.41 P/E Ratio
0% Div Yield
317,572 Volume
7.83 Eps
$ 144.77
Previous Close
Day Range
142.88 144.99
Year Range
131.76 179.6
Want to track DVA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 6 days
DaVita HealthCare (DVA) Rises As Market Takes a Dip: Key Facts

DaVita HealthCare (DVA) Rises As Market Takes a Dip: Key Facts

In the most recent trading session, DaVita HealthCare (DVA) closed at $151.37, indicating a +0.39% shift from the previous trading day.

Zacks | 4 months ago
DaVita Stock Declines 1.2% in 3 Months: Here's How to Play

DaVita Stock Declines 1.2% in 3 Months: Here's How to Play

DVA's stable core business and global expansion are offset by rising labor costs and declining commercial mix, creating a mixed outlook for investors.

Zacks | 4 months ago
DaVita HealthCare (DVA) Exceeds Market Returns: Some Facts to Consider

DaVita HealthCare (DVA) Exceeds Market Returns: Some Facts to Consider

DaVita HealthCare (DVA) reachead $150.78 at the closing of the latest trading day, reflecting a +0.25% change compared to its last close.

Zacks | 4 months ago
DaVita HealthCare (DVA) Increases Yet Falls Behind Market: What Investors Need to Know

DaVita HealthCare (DVA) Increases Yet Falls Behind Market: What Investors Need to Know

The latest trading day saw DaVita HealthCare (DVA) settling at $149.83, representing a +0.31% change from its previous close.

Zacks | 4 months ago
DaVita HealthCare (DVA) Suffers a Larger Drop Than the General Market: Key Insights

DaVita HealthCare (DVA) Suffers a Larger Drop Than the General Market: Key Insights

DaVita HealthCare (DVA) closed the most recent trading day at $141.12, moving -1.06% from the previous trading session.

Zacks | 4 months ago
Here's why this Warren Buffett stock plunged 11% in a day

Here's why this Warren Buffett stock plunged 11% in a day

Shares of Davita Inc. (NYSE: DVA) plunged 11% on February 14, as the dialysis provider issued a weaker-than-expected 2025 earnings outlook, citing rising patient care costs, supply constraints, and ongoing dialysis center closures.

Finbold | 5 months ago
Why DaVita Inc Stock Is Plummeting Today

Why DaVita Inc Stock Is Plummeting Today

Shares of DaVita Inc (DVA -11.09%) are trading lower on Friday. The company's stock lost 11.1% as of market close but lost as much as 15.2% earlier in the day.

Fool | 5 months ago
DaVita's stock leads S&P 500 decliners after Berkshire pares stake. Its soft guidance isn't helping.

DaVita's stock leads S&P 500 decliners after Berkshire pares stake. Its soft guidance isn't helping.

DaVita shares were tumbling 13.5% Friday to lead S&P 500 decliners, after Warren Buffett's Berkshire Hathaway pared its stake in the provider of kidney dialysis.

Marketwatch | 5 months ago
Here's why Warren Buffett dumped $31 million worth of this stock

Here's why Warren Buffett dumped $31 million worth of this stock

Warren Buffett, the ‘Oracle of Omaha', managed to attain a roughly $142 billion net worth by consistently outperforming the markets. The Berkshire Hathaway (NYSE: BRK.B) chief executive officer (CEO) and chairman did so by utilizing a careful, level-headed approach to investing.

Finbold | 5 months ago
Warren Buffett's Berkshire Hathaway sells some DaVita; Shares fall on disappointing guidance

Warren Buffett's Berkshire Hathaway sells some DaVita; Shares fall on disappointing guidance

DaVita shares tumbled after issuing a weak outlook amid rising care costs, while big investor Berkshire offloaded some shares in a pre-planned agreement.

Cnbc | 5 months ago
DaVita Inc. (DVA) Q4 2024 Earnings Call Transcript

DaVita Inc. (DVA) Q4 2024 Earnings Call Transcript

DaVita Inc. (NYSE:DVA ) Q4 2024 Earnings Conference Call February 13, 2025 5:00 PM ET Company Participants Nic Eliason - Group VP, IR Javier Rodriguez - CEO Joel Ackerman - CFO Conference Call Participants Joanna Gajuk - Bank of America AJ Rice - UBS Pito Chickering - Deutsche Bank Justin Lake - Wolfe Research Andrew Mok - Barclays Ryan Langston - TD Cowen Operator Good evening. My name is Michelle, and I will be your conference facilitator today.

Seekingalpha | 5 months ago
Berkshire sells some DaVita shares, cuts stake to 45%

Berkshire sells some DaVita shares, cuts stake to 45%

Berkshire Hathaway said on Thursday night it sold 203,091 shares of DaVita , reducing its stake in the kidney dialysis services provider to about 35.89 million shares, a 45% stake worth nearly $6.4 billion.

Reuters | 5 months ago
Loading...
Load More